跳至主要内容
临床试验/NCT06710405
NCT06710405招募中4 期

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery:Prospective, Randomized Controlled Trial

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年12月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
80
试验地点
1
主要终点
FLACC (ace, Legs, Activity, Cry, Consolability scale) Score

研究概览

简要总结

This study aims to investigate the efficacy of intraoperative intravenous lidocaine infusion on postoperative pain management and recovery in pediatric patients undergoing thoracoscopic pulmonary resection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients aged under 7 years undergoing thoracoscopic pulmonary resection

排除标准

  • cardiac dysfunction requiring vasopressors or inotropic agents
  • atrioventricular block or bradycardia
  • Liver or kidney dysfunction
  • Hypersensitivity to local anesthetics

研究组 & 干预措施

Lidocaine group

Experimental

Anesthesia induction is performed according to the standard protocol. Monitoring includes electrocardiography, pulse oximetry, arterial blood pressure, depth of anesthesia (Patient State Index, PSI), and pain score (Analgesia Nociception Index).

In the lidocaine group, a single bolus dose of lidocaine 1.5 mg/kg is administered concurrently with the induction of anesthesia, followed by a continuous infusion of lidocaine at a rate of 1.5 mg/kg/hr.

干预措施: Lidocaine (drug) (Drug)

Control group

Placebo Comparator

The control group receives a continuous infusion of normal saline in the same volume as that administered to the lidocaine group.

干预措施: Saline infusion (placebo) (Drug)

结局指标

主要结局

FLACC (ace, Legs, Activity, Cry, Consolability scale) Score

时间窗: up to 1 hour after surgery

Highest FLACC Score recorded in the postanesthesia care unit (The scale is scored in a range of 0-10 with 0 representing no pain.)

次要结局

  • Remifentanil dose(throughout surgery (up to 3 hours))
  • ANI (Analgesia Nociception Index)(throughout surgery (up to 3 hours))
  • FLACC scores(6 hours, 12 hours, and 24 hours postoperatively)
  • Total analgesic dosage administered postoperatively(up to 3 days after surgery)
  • Postoperative complications(until discharge (up to 3-4 days after surgery))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji-Hyun Lee

Associate Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验